BioTech Illumina, Inc. (ILMN)’s Jay Flatley Talks about Record Quarter and Sales in ChinaBy Alex OleinicJuly 24, 2014 Genome sequencing technology maker Illumina, Inc. (NASDAQ:ILMN) posted a record second quarter revenue of $448 million, beating estimates of $427…